These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane. Wallace DR, Booze RM. J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063 [Abstract] [Full Text] [Related]
3. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride. Booze RM, Wallace DR. Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338 [Abstract] [Full Text] [Related]
6. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. Mohell N, Sällemark M, Rosqvist S, Malmberg A, Högberg T, Jackson DM. Eur J Pharmacol; 1993 Jul 06; 238(1):121-5. PubMed ID: 8405075 [Abstract] [Full Text] [Related]
7. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus. Schoemaker H. Eur J Pharmacol; 1993 Oct 05; 242(3):R1-2. PubMed ID: 8281986 [Abstract] [Full Text] [Related]
10. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB. J Pharmacol Exp Ther; 1994 Feb 05; 268(2):935-42. PubMed ID: 8114008 [Abstract] [Full Text] [Related]
11. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Booth RG, Baldessarini RJ, Marsh E, Owens CE. Brain Res; 1994 Oct 31; 662(1-2):283-8. PubMed ID: 7859086 [Abstract] [Full Text] [Related]
14. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Millan MJ, Audinot V, Rivet JM, Gobert A, Vian J, Prost JF, Spedding M, Peglion JL. Eur J Pharmacol; 1994 Aug 01; 260(2-3):R3-5. PubMed ID: 7988633 [Abstract] [Full Text] [Related]
15. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ. J Pharmacol Exp Ther; 1995 Nov 01; 275(2):899-913. PubMed ID: 7473181 [Abstract] [Full Text] [Related]
16. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors. Levant B, Grigoriadis DE, De Souza EB. Eur J Pharmacol; 1995 May 24; 278(3):243-7. PubMed ID: 7589161 [Abstract] [Full Text] [Related]
17. S-(+)-aporphines are not selective for human D3 dopamine receptors. Kula NS, Baldessarini RJ, Kebabian JW, Neumeyer JL. Cell Mol Neurobiol; 1994 Apr 24; 14(2):185-91. PubMed ID: 7842476 [Abstract] [Full Text] [Related]
18. Characterization of the human dopamine D3 receptor expressed in transfected cell lines. MacKenzie RG, VanLeeuwen D, Pugsley TA, Shih YH, Demattos S, Tang L, Todd RD, O'Malley KL. Eur J Pharmacol; 1994 Jan 01; 266(1):79-85. PubMed ID: 7907989 [Abstract] [Full Text] [Related]
19. Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT. Vessotskie JM, Kung MP, Chumpradit S, Kung HF. Brain Res; 1997 Dec 05; 778(1):89-98. PubMed ID: 9462880 [Abstract] [Full Text] [Related]
20. Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography. Kaichi Y, Nonaka R, Hagino Y, Watanabe M. Can J Physiol Pharmacol; 2000 Jan 05; 78(1):7-11. PubMed ID: 10741754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]